Jennifer M. Matro

3.6k total citations
32 papers, 765 citations indexed

About

Jennifer M. Matro is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jennifer M. Matro has authored 32 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jennifer M. Matro's work include Breast Cancer Treatment Studies (7 papers), BRCA gene mutations in cancer (6 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). Jennifer M. Matro is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), BRCA gene mutations in cancer (6 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). Jennifer M. Matro collaborates with scholars based in United States, Philippines and Poland. Jennifer M. Matro's co-authors include Joseph E. Blaney, Angela DeMichele, Stephen S. Whitehead, Brian R. Murphy, Kevin R. Fox, Amy S. Clark, Bonnie Ky, Angela R. Bradbury, Susan M. Domchek and Joseph R. Carver and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer.

In The Last Decade

Jennifer M. Matro

30 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer M. Matro United States	11	259	242	229	117	113	32	765
Shane Killeen Ireland	16	74 0.3×	104 0.4×	244 1.1×	100 0.9×	53 0.5×	40	868
Patricia Castillo United States	12	46 0.2×	89 0.4×	128 0.6×	32 0.3×	18 0.2×	31	613
Kathleen Coard Jamaica	17	75 0.3×	33 0.1×	103 0.4×	30 0.3×	51 0.5×	61	651
Wegene Borena Austria	19	69 0.3×	53 0.2×	333 1.5×	29 0.2×	455 4.0×	61	1.4k
Ν. Παπαντωνίου Greece	20	195 0.8×	63 0.3×	23 0.1×	24 0.2×	32 0.3×	33	1.1k
Hanna Kelly United States	11	43 0.2×	86 0.4×	275 1.2×	48 0.4×	38 0.3×	17	502
Setsuo Okada Japan	13	346 1.3×	22 0.1×	83 0.4×	52 0.4×	26 0.2×	48	1.1k
Norbert Winer France	12	118 0.5×	20 0.1×	72 0.3×	57 0.5×	114 1.0×	49	884
Eoghan McCarthy Ireland	17	40 0.2×	40 0.2×	70 0.3×	70 0.6×	52 0.5×	44	787
John P. Whitecar United States	13	271 1.0×	53 0.2×	334 1.5×	19 0.2×	33 0.3×	18	977

Countries citing papers authored by Jennifer M. Matro

Since Specialization

Citations

This map shows the geographic impact of Jennifer M. Matro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer M. Matro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer M. Matro more than expected).

Fields of papers citing papers by Jennifer M. Matro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer M. Matro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer M. Matro. The network helps show where Jennifer M. Matro may publish in the future.

Co-authorship network of co-authors of Jennifer M. Matro

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer M. Matro. A scholar is included among the top collaborators of Jennifer M. Matro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer M. Matro. Jennifer M. Matro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Kristine, Michael Salerno, Payal D. Shah, Jennifer M. Matro, & Michael J. LaRiviere. (2022). Severe acute radiation dermatitis after palbociclib therapy in the setting of palliative radiotherapy. Journal of Oncology Pharmacy Practice. 29(3). 764–767. 1 indexed citations

Makhlin, Igor, Nicholas P. McAndrew, E. Paul Wileyto, et al.. (2022). Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer. npj Breast Cancer. 8(1). 122–122. 5 indexed citations

Nazarian, Susanna M., Fei Xie, Amy S. Clark, et al.. (2020). Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience. Journal of Surgical Oncology. 121(3). 447–455. 6 indexed citations

Demissei, Biniyam G., Rebecca A. Hubbard, Liyong Zhang, et al.. (2019). CHANGES IN CARDIOVASCULAR BIOMARKERS WITH BREAST CANCER THERAPY AND ASSOCIATIONS WITH CARDIAC DYSFUNCTION. Journal of the American College of Cardiology. 73(9). 678–678. 6 indexed citations

Keele, Luke, Kevin R. Fox, Amy S. Clark, et al.. (2019). Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?. Breast Cancer Research and Treatment. 177(1). 137–143. 10 indexed citations

Upshaw, Jenica, Brian S. Finkelman, Rebecca A. Hubbard, et al.. (2019). Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy. JACC. Cardiovascular imaging. 13(1). 198–210. 83 indexed citations

Upshaw, Jenica, Brian S. Finkelman, Rebecca A. Hubbard, et al.. (2019). CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION WITH CONTEMPORARY BREAST CANCER THERAPY. Journal of the American College of Cardiology. 73(9). 1676–1676. 1 indexed citations

Finkelman, Brian S., Mary Putt, Hari K. Narayan, et al.. (2017). Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer. Journal of the American College of Cardiology. 70(2). 152–162. 87 indexed citations

Tchou, Julia, Yangbing Zhao, Jennifer M. Matro, et al.. (2017). Abstract P6-10-08: Preliminary results of a first in human Phase 1 clinical trial to demonstrate safety and feasibility of chimeric antigen receptor T (CART) cells directed against c-Met in the treatment of breast cancer. Cancer Research. 77(4_Supplement). P6–10. 1 indexed citations

10.

Narayan, Hari K., Benjamin French, Abigail Khan, et al.. (2016). Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics–Related Cardiac Dysfunction. JACC. Cardiovascular imaging. 9(10). 1131–1141. 81 indexed citations

11.

Matro, Jennifer M. & Yehoda M. Martei. (2015). Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes. Breast Cancer Targets and Therapy. 7. 337–337. 8 indexed citations

12.

Matro, Jennifer M., et al.. (2014). Bilateral Hypoglossal Nerve Palsy Due To Breast Cancer Skull Base Metastases. 10(5).

13.

Hall, Michael J., Patrick M. Boland, Karen Ruth, et al.. (2014). Incorporating genomic testing using next-generation sequencing (NGS) into clinical practice: Genetic counselors’ (GC) experience, knowledge, and perceived competence.. Journal of Clinical Oncology. 32(15_suppl). e17624–e17624. 1 indexed citations

14.

Matro, Jennifer M., Jian Yu, Michael C. Heinrich, et al.. (2014). Correlation of PET/CT and CT RECIST response in GIST patients with PDGFRA D842V gene mutations treated with crenolanib.. Journal of Clinical Oncology. 32(15_suppl). 10546–10546. 3 indexed citations

15.

Matro, Jennifer M. & Lori J. Goldstein. (2013). How Do I Follow Patients With Early Breast Cancer After Completing Adjuvant Therapy. Current Treatment Options in Oncology. 15(1). 63–78. 6 indexed citations

16.

Matro, Jennifer M., et al.. (2012). Cost sharing and hereditary cancer risk: Predictors of willingness-to-pay for genetic testing.. Journal of Clinical Oncology. 30(15_suppl). 1544–1544. 1 indexed citations

17.

Su, H. Irene, Mary D. Sammel, Luke Velders, et al.. (2009). Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive‐aged breast cancer survivors. Cancer. 116(3). 592–599. 93 indexed citations

18.

Su, H. Irene, Mary D. Sammel, Luke Velders, et al.. (2009). Association of cyclophosphamide drug–metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertility and Sterility. 94(2). 645–654. 45 indexed citations

19.

Shah, Samir S., Ebbing Lautenbach, Warren B. Bilker, et al.. (2007). Bloodstream infections after median sternotomy at a children’s hospital. Journal of Thoracic and Cardiovascular Surgery. 133(2). 435–440. 35 indexed citations

20.

Lautenbach, Ebbing, Warren B. Bilker, Jennifer M. Matro, et al.. (2007). Risk Factors for Mediastinitis Following Median Sternotomy in Children. The Pediatric Infectious Disease Journal. 26(7). 613–618. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact